{"name":"Mostafa Bahaa","slug":"mostafa-bahaa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Febuxostat Tablets","genericName":"Febuxostat Tablets","slug":"febuxostat-tablets","indication":"Other","status":"marketed"},{"name":"Valsartan 80 mg","genericName":"Valsartan 80 mg","slug":"valsartan-80-mg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Febuxostat Tablets","genericName":"Febuxostat Tablets","slug":"febuxostat-tablets","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Valsartan 80 mg","genericName":"Valsartan 80 mg","slug":"valsartan-80-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9acExCdkRscEhDVUhkN2lLQnFUTFI0T0Y5eVlKMmpyTUdpbDdwdHlNa2N6MGNYdWVwcGZwZGM1NWNsaE55bVhpZTRTVFhseHc4LUJ4THV2NWhxanIwTjdhN19pc3RpVHJ3azAw?oc=5","date":"2024-11-26","type":"trial","source":"Wiley Online Library","summary":"Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double-blind study: New insights on TARC, CTACK, TSLP, and E-selectin - Wiley Online Library","headline":"Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double-blind st","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}